IL223012B
Pharmaceutical formulation in the form of bilayered tablets comprising atorvastatin and irbesartan
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
55 members in 29 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 20100045636 | Republic of Korea | A | |
| 20100053782 | Republic of Korea | A | |
| 2011003549 | Republic of Korea | W |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| CA2798363A1 | Canada | A1 | |
| WO2011142621A2 | World Intellectual Property Organization (WIPO) | A2 | |
| KR20110126020A | Republic of Korea | A | |
| TW201200166A | Taiwan Province of China | A | |
| WO2011142621A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2012031313A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AR081032A1 | Argentina | A1 | |
| CR20120545A | Costa Rica | A | |
| CO6592025A2 | Colombia | A2 | |
| AU2011251085A1 | Australia | A1 | |
| AU2011301131A1 | Australia | A1 | |
| MX2012013175A | Mexico | A | |
| SG185778A1 | Singapore | A1 | |
| US2013028974A1 | United States of America | A1 | |
| IL223012A0 | Israel | A0 | |
| KR20130024940A | Republic of Korea | A | |
| EP2568972A2 | European Patent Office (EPO) | A2 | |
| CN103002883A | China | A | |
| KR101248804B1 | Republic of Korea | B1 | |
| US2013097807A1 | United States of America | A1 | |
| EA201291247A1 | Eurasian Patent Organization (EAPO) | A1 | |
| AU2011301131B2 | Australia | B2 | |
| MA34313B1 | Morocco | B1 | |
| JP2013526516A | Japan | A | |
| EP2611980A1 | European Patent Office (EPO) | A1 | |
| HK1181685A | Hong Kong, China | A | |
| HK1181685A1 | Hong Kong, China | A1 | |
| NZ605060A | New Zealand | A | |
| ZA201209481B | South Africa | B | |
| EP2568972A4 | European Patent Office (EPO) | A4 | |
| US8844604B2 | United States of America | B2 | |
| NZ604402A | New Zealand | A | |
| UA107967C2 | Ukraine | C2 | |
| CN103002883B | China | B | |
| MY157307A | Malaysia | A | |
| AU2016203739A1 | Australia | A1 | |
| EA023959B1 | Eurasian Patent Organization (EAPO) | B1 | |
| BR112012029064A2 | Brazil | A2 | |
| JP5969466B2 | Japan | B2 | |
| MX342868B | Mexico | B | |
| EP2568972B1 | European Patent Office (EPO) | B1 | |
| PT2568972T | Portugal | T | |
| EP2611980A4 | European Patent Office (EPO) | A4 | |
| SI2568972T1 | Slovenia | T1 | |
| AU2016203739B2 | Australia | B2 | |
| DK2568972T3 | Denmark | T3 | |
| ES2645726T3 | Spain | T3 | |
| PL2568972T3 | Poland | T3 | |
| CA2798363C | Canada | C | |
| HUE036638T2 | Hungary | T2 | |
| IL223012A | Israel | A | |
| IL223012BThis record | Israel | B | |
| BR112012029064B1 | Brazil | B1 | |
| EP2611980B1 | European Patent Office (EPO) | B1 | |
| BR112012029064B8 | Brazil | B8 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent not in force due to non-payment of renewal feesMM9K | MM9K | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 223012
- Application
- 223012
Titles2
- English
- Pharmaceutical formulation in the form of bilayered tablets comprising atorvastatin and irbesartan
- Hebrew
- תכשירי רוקחות בצורת טבליות בעל שתי שכבות המכילים אטורווסטאטין ואירבסרטן
Classification
- CPC, 15
- A61K9/209
- A61K31/40
- A61K45/06
- A61K9/1611
- A61K9/1652
- A61K9/2009
- A61K9/2054
- A61K31/415
- A61P3/00
- A61P3/06
- A61P43/00
- A61P9/12
- A61K9/20
- A61K47/36
- A61K31/41